Примери за използване на Patients were randomised на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Patients were randomised to the two arms.
Pivotal studies 033 and 049 in immunocompetent patients were randomised, double-blind, placebo controlled trials.
Patients were randomised to either Omidria or placebo(1:1).
In an additional two-centre study, 26 patients were randomised to the tacrolimus versus 24 patients to the ciclosporin group.
Patients were randomised to bolus 5-FU and leucovorin.
In an additional two-centre study, 26 patients were randomised to the tacrolimus versus 24 patients to the ciclosporin group.
Patients were randomised(1:1:1) to 1 of 3 treatment arms.
In this study, 428 patients were randomised to one of two treatment groups.
Patients were randomised(1:1) to one of the following treatment arms.
In this study, 212 patients were randomised and received either palifermin or placebo.
Patients were randomised to 40 mg of Trudexa i.
Eight hundred and twenty-nine patients were randomised(292 FOLFOX-4, 293 Avastin +_FOLFOX-4 and 244 Avastin monotherapy).
Patients were randomised in a 1:1:1 ratio to one of 3 treatment arms.
Of these, 958 patients were randomised to duloxetine and 955 to placebo.
Patients were randomised to placebo, ADASUVE 4.5 mg and ADASUVE 9.1 mg.
At week 8, 45 patients were randomised and received 5 mg/kg infliximab at either.
Patients were randomised(1:1) to receive either atezolizumab or docetaxel.
Approximately 350 patients were randomised into each of the 4 study arms in the Part II of the trial.
Patients were randomised(1:1) to receive either atezolizumab or chemotherapy.
Approximately 350 patients were randomised into each of the 4 trial arms in the Part II of the trial.
Patients were randomised to receive placebo, Simponi 50 mg, or Simponi 100 mg.
In this trial, 1002 patients were randomised in a 2x2 factorial design to one of the following 4 arms.
Patients were randomised to 40 mg of Humira or placebo every other week for 24 weeks.
Patients were randomised to receive 40 mg aprepitant, 125 mg aprepitant, or 4 mg ondansetron.
Patients were randomised to treatment with Xeloda combined with irinotecan(XELIRI) and bevacizumab.
Patients were randomised to either dexamethasone or placebo in addition to their assigned treatment.
Patients were randomised to treatment with docetaxel alone 100 mg/m2 as a.
Patients were randomised to receive Aranesp at 500 mcg once every three weeks or 2.25 mcg/kg once weekly.
Patients were randomised to one of five treatment groups(tadalafil 2.5 mg, 10 mg, 20 mg, 40 mg, or placebo).
Patients were randomised into the study a median of 40 days after completing their final platinum chemotherapy.